Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | -0.005 | 0.9 |
mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.9 |
mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.9 |
mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.0048 | 0.9 |
mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | 0.0043 | 0.9 |
mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |